Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ginevra Urbani

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Recent Advances in Inflammation & Allergy Drug Discovery|April 29, 2025
COVID-19: An Updated View as of 2025Stefano Fiorucci, Ginevra Urbani
Expert Opinion on Investigational Drugs|August 9, 2025
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectivesStefano Fiorucci, Ginevra Urbani
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver DisordersStefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.
Cells|October 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future DevelopmentsStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Cells|September 27, 2024
Current Landscape and Evolving Therapies for Primary Biliary CholangitisStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Biochemical Pharmacology|December 11, 2023
Bile acids and bile acid activated receptors in the treatment of Covid-19Stefano Fiorucci, Ginevra Urbani, Michele Biagioli, et al.
Cells|April 25, 2025
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as PostbioticsGinevra Urbani, Elena Rondini, Eleonora Distrutti, et al.
Scandinavian Journal of Gastroenterology|February 2, 2026
A novel pathogenic variant for dubin-johnson syndrome in a case of hyperbilirubinemia and metabolic associated fatty liver diseaseGinevra Urbani, Maria Antonella Burza, Johan Waern, et al.
Progress in Lipid Research|August 9, 2024
Immunology of bile acids regulated receptorsStefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|August 19, 2022
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Recent Advances in Inflammation & Allergy Drug Discovery|April 29, 2025
COVID-19: An Updated View as of 2025Stefano Fiorucci, Ginevra Urbani
Expert Opinion on Investigational Drugs|August 9, 2025
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectivesStefano Fiorucci, Ginevra Urbani
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver DisordersStefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.
Cells|October 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future DevelopmentsStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Cells|September 27, 2024
Current Landscape and Evolving Therapies for Primary Biliary CholangitisStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Biochemical Pharmacology|December 11, 2023
Bile acids and bile acid activated receptors in the treatment of Covid-19Stefano Fiorucci, Ginevra Urbani, Michele Biagioli, et al.
Cells|April 25, 2025
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as PostbioticsGinevra Urbani, Elena Rondini, Eleonora Distrutti, et al.
Scandinavian Journal of Gastroenterology|February 2, 2026
A novel pathogenic variant for dubin-johnson syndrome in a case of hyperbilirubinemia and metabolic associated fatty liver diseaseGinevra Urbani, Maria Antonella Burza, Johan Waern, et al.
Progress in Lipid Research|August 9, 2024
Immunology of bile acids regulated receptorsStefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|August 19, 2022
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Pageof 3